Respiratory syncytial virus vaccination in pregnancy is not effective enough at reducing infant infections

Review of: Madhi SA, Polack F, Piedra P et al. Respiratory syncytial virus vaccination during pregnancy and effects in infants. N Engl J Med 2020;383:426–39.

Design: Randomised placebo controlled trial.

Allocation: 1:1 (first global season) and 2:1 ratio (subsequent seasons) vaccine to placebo.

Blinding: Observer blind.

Setting: Multinational (87 sites in 11 countries).

Participants: 4636 healthy pregnant women aged 18–40 years between 28 and 36 weeks gestation. Exclusion criteria were essentially any mother with any underlying health condition or on any medication.

Intervention: Women were randomised to receive either single dose of intramuscular respiratory syncytial virus (RSV) F-protein vaccine or placebo vaccine.

Outcomes: Primary outcome was vaccine efficacy (VE) of prevention of medically significant RSV lower respiratory tract infection (MS-RSV …

留言 (0)

沒有登入
gif